SEARCH HEALTH CONDITIONS BY ALPHABETS
Dyspareunia
Medications for Dyspareunia
Other names: Painful coitus (female); Painful intercourse
About Dyspareunia: Dyspareunia is the incidence of pain during sexual intercourse.
Drugs Used to Treat Dyspareunia
The following list of medications have been used at the treating this illness, or in some way related to.
Medication title | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
---|---|---|---|---|---|---|---|
Osphena | Rx | X | N | 2-2 testimonials | 6.4 | ||
Generic title: ospemifene systemic Medication class: selective estrogen receptor modulators For customers: dosage, interactions, side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
Intrarosa | Rx/OTC | N | N | 54 testimonials | 6.0 | ||
Generic title: dehydroepiandrosterone systemic For customers: dosage, interactions, side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
ospemifene | Rx | X | N | 2-2 testimonials | 6.4 | ||
Generic title: ospemifene systemic Brand title: Osphena Medication class: selective estrogen receptor modulators For customers: dosage, interactions, For specialists: Az Drug Facts, AHFS DI Monograph | |||||||
dehydroepiandrosterone | Rx/OTC | N | N | 55 testimonials | 6.1 | ||
Generic title: dehydroepiandrosterone systemic Brand title: Intrarosa Drug class: Indices goods For customers: interactions, For specialists: Az Drug Facts, AHFS DI Monograph, Natural Product Monographs | |||||||
estradiol | Rx | X | N | 1-2 testimonials | 6.5 | ||
Generic title: estradiol topical Brand title: Imvexxy Medication class: estrogens, mixed vaginal brokers For customers: dosage, interactions, For specialists: Az Drug Facts, Prescribing Information | |||||||
Imvexxy | Rx | X | N | 1-2 testimonials | 6.5 | ||
Generic title: estradiol topical Medication class: estrogens, mixed vaginal brokers For consumers: dosage, interactions, side effects | |||||||
Legend
Rx | prescription-only |
---|---|
OTC | Over the Counter |
Rx/OTC | Prescription or Over The Counter |
Off Label | This medication may well not be approved by the FDA for the treatment of this illness. |
Pregnancy Category | |
---|---|
A | Adequate and well-controlled studies have failed to present a risk to the embryo in the first trimester of pregnancy (and there is no evidence of risk in later trimesters). |
B | Animal reproduction studies have failed to show a risk to the fetus and there are no sufficient and well-controlled studies in pregnant women. |
C | Animal reproduction studies have demonstrated a negative effect in the fetus and there are no sufficient and well-controlled studies in humans, but potential benefits may warrant used in pregnant women despite potential risks. |
D | there was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant used in pregnant women despite potential risks. |
X | Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved with used in pregnant women clearly outweigh potential benefits. |
N | FDA have not classified this drug. |
Controlled Substances Act (CSA) Program | |
---|---|
N | Is not subject to the Controlled Substances Act. |
Inch | features a high possibility of misuse. Has no currently accepted medical use in treatment in the USA. There`s a lack of accepted safety for use under medical supervision. |
Two | features a high possibility of misuse. Has a currently accepted medical use in treatment in the USA or a currently accepted medical use with severe restrictions. Abuse may cause severe psychological or physical dependency. |
3 | features a possibility for abuse less than those in schedules 1 and 2 2. Has a currently accepted medical use in treatment in the USA. Abuse may lead to physical dependence or high psychological dependence. |
4 | features a low potential for abuse in accordance with those in program 3. It has a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence relative to those in program 3. |
5 | features a low potential for abuse in accordance with those in program 4. Has a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence. |
Infection | |
---|---|
X | Interacts with Alcohol. |
Browse Treatment Plans
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- Runciman
- S
- T
- U
- V
- W
- X
- Y
- Z
Further advice
Always consult your healthcare provider to ensure the information displayed on these pages relates to a circumstances.